Allogeneic HCT Outcomes in MF Patients Exposure to Ruxolitinib During Transplantation

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT04526223

Title field or adapter rule

protocolSection.identificationModule.officialTitle

Ingested At

2026-04-28T10:38:42.436133+00:00

Published At

2022-04-15T00:00:00+00:00

Record Updated At

2022-04-15

Timestamp Basis

source retrieval time was not retained by the feed adapter

Date limitation

source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Time of Hematopoietic Reconstruction"]

protocolSection.statusModule.lastUpdatePostDateStruct.date

"2022-04-15"

protocolSection.identificationModule.nctId

"NCT04526223"

protocolSection.identificationModule.officialTitle

"Allogeneic HCT Outcomes in MF Patients Exposure to Ruxolitinib During Transplantation"

protocolSection.statusModule.overallStatus

"UNKNOWN"

protocolSection.designModule.phases

["NA"]

protocolSection.statusModule.resultsFirstPostDateStruct.date

""

Study condition terms

• Time of Hematopoietic Reconstruction (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.